IBM health officer heads to Cota as CMO

Andrew Norden, MD, a former health officer with IBM, joined Cota as CMO.

Cota, a New York City-based healthcare analytics startup, helps providers, payers and life science companies apply precision medicine by categorizing patient demographic factors, diseases and therapies. AS CMO of Cota, Dr. Norden will oversee clinical partnerships and solutions.

Dr. Norden most recently served as the deputy chief health officer for oncology and genomics at IBM Watson Health. Prior to IBM Watson Health, he served as associate CMO and medical director of satellites and network affiliates at Boston-based Dana-Farber Cancer Institute.

Dr. Norden, who is board-certified and fellowship-trained in neuro-oncology, also holds a master of public health from Boston-based Harvard T.H. Chan School of Public Health and a master of business administration from University of Massachusetts at Amherst.

"I look forward to bringing my clinical and data-driven technology experience to take Cota to the next level, designing and developing effective solutions that will completely transform how physicians leverage data to optimize patient care," Dr. Norden said.

The startup's former CMO, Stuart Goldberg, MD, will remain part of Cota and lead research and publication efforts as its chief scientific officer.

More articles on data analytics & precision medicine:
Intermountain rolls out DNA-based test to personalize drug prescribing
UC Davis to use precision medicine in pancreatic cancer care
Kalorama: Apple, Google, IBM make waves in healthcare analytics market

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months